Last reviewed · How we verify
NCT04232462
A Multicentric Validation Study on the Accuracy of Artificial Intelligence Assisted System in Clinical Application of Digestive Endoscopy
trial testing Endoscopists refer to AI for diagnosis in Gastrointestinal Disease in 10,000 participants. Status unknown.
31 December 2025
Quick facts
| Lead sponsor | Renmin Hospital of Wuhan University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 1 January 2020 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Endoscopists refer to AI for diagnosis
Conditions studied
- Gastrointestinal Disease — all drugs for Gastrointestinal Disease →
- Endoscopy — all drugs for Endoscopy →
- Artificial Intelligence — all drugs for Artificial Intelligence →
Sponsor
Renmin Hospital of Wuhan University
Who can join
18 and older, any sex, with Gastrointestinal Disease or Endoscopy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an artificial intelligence-based optical artificial intelligence assisted system that can assist endoscopists in improving the quality of endoscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04232462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Endoscopists refer to AI for diagnosis
Trials testing the same drug.
- NCT04216901 — A Single Center Study on the Effectiveness and Safety of Polyp Classification With Artificial Intelligence · unknown
Other recruiting trials for Gastrointestinal Disease
Currently open trials in the same condition.
- NCT05053191 — Advancing Nursing Practices in Hospital Oncology Care · NA · active not recruiting
- NCT04949282 — Spanish Series of Patients Treated With the Radionuclide Lutetium177 · recruiting
- NCT03566160 — Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy · NA · active not recruiting
Other Renmin Hospital of Wuhan University trials
Trials by the same sponsor.
- NCT07587294 — Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patien · NA · not yet recruiting
- NCT07269509 — Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhi · NA · not yet recruiting
- NCT07151560 — Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in · Phase 2 · not yet recruiting
- NCT07085221 — Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock · NA · recruiting
- NCT06614985 — The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04232462 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Renmin Hospital of Wuhan University
- Last refreshed: 8 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04232462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing